Loading clinical trials...

Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Health Workers | Clinical Trials | Clareo Health

COMPLETEDPHASE4

Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Health Workers

NCT00301015•Karolinska University Hospital

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the efficiency of a rapid diagnostic test (Paracheck Pf) for the diagnosis of uncomplicated Plasmodium falciparum malaria by community health workers at village level in Tanzania and how the use of rapid diagnostic test may influence prescription of antimalarial drugs. The hypothesis is that rapid diagnostic tests used by community health workers will reduce the use of antimalarial drugs (Coartem; Novartis) by 30% without affecting the health outcome.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Fever
•Informed consent

Exclusion Criteria

•Severe clinical manifestations, which require immediate referral
•Pregnancy
•Previous enrollment in the study within the last 28 days

Locations (1)

Villages

Kibaha, Kibaha District, Tanzania

Key Dates

Start Date

March 1, 2006

Completion Date

August 1, 2006

Last Updated

November 1, 2007

Enrollment

3,005

ACTUAL participants

Conditions

Uncomplicated Plasmodium Falciparum Malaria

Interventions

Rapid diagnostic test for malaria

DEVICE

Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial

NCT05764746

Uncomplicated Plasmodium Falciparum Malaria

View study

COMPLETEDPHASE2

Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria

NCT03167242

Acute Uncomplicated Plasmodium Falciparum Malaria

View study

COMPLETEDPHASE2/PHASE3

Phase II Efficacy Study of Artefenomel & Piperaquine in Adults & Children With P. Falciparum Malaria.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 1, 2007Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.